Semra Paydaş

Cemiplimab monotherapy for first-line treatment of advanced non-small-cell lung cancer with PD-L1 of at least 50%: a multicentre, open-label, global, phase 3, randomised, controlled trial

Ahmet Sezer, Mahmut Gümüş, Igor Bondarenko et al. · The Lancet · 2021 · 799 citations

Medicine, Oncology, Pharmacology +13

Granulocytic sarcoma: 32 cases and review of the literature

Semra Paydaş, Suzan Zorludemir, Melek Ergin · Leukemia & lymphoma/Leukemia and lymphoma · 2006 · 298 citations

Medicine, Oncology, Pathology +10

Bone marrow necrosis: Clinicopathologic analysis of 20 cases and review of the literature

Semra Paydaş, Melek Ergin, Fikri Başlamıslı et al. · American Journal of Hematology · 2002 · 145 citations · Full text

Medicine, Hematology, Pathology +14

Clinical and prognostic significance of PD-1 and PD-L1 expression in sarcomas

Semra Paydaş, Mehmet Deveci, Gülfiliz Gönlüşen · Medical Oncology · 2016 · 90 citations

Medicine, Oncology, Pathology +14

Clinical significance and frequency of Blastocystis hominis in Turkish patients with hematological malignancy.

Yeşim Taşova, B Sahin, Soner Koltaş et al. · PubMed · 2000 · 88 citations · Full text

Medicine, Hematology, Infectious Diseases +17